CHronic Nonbacterial Osteomyelitis International Registry
Studying Chronic nonbacterial osteomyelitis/Chronic recurrent multifocal osteomyelitis
Last synced from ClinicalTrials.gov
Key facts
- Sponsor
- Seattle Children's Hospital
- Intervention
- Methotrexate(drug)
- Enrollment
- 2000 enrolled
- Eligibility
- 21 years · All sexes
- Timeline
- 2018 – 2050
Study locations (1)
- Seattle Children's Hospital, Seattle, Washington, United States
Collaborators
Boston Children's Hospital, Boston, MA, USA · Hospital for Special Surgery, New York · Joseph M Sanzari Children's Hospital, Hackensack University Medical Center, Hackensack, NJ, USA · Riley Children's Hospital, Indianapolis, IN, USA · University of North Carolina, Chapel Hill, NC, USA · Royal Children's Hospital · Hacettepe University · Bambino Gesù Children's Hospital, Rome, Italy · University of British Columbia, Vancouver, BC, Canada · Meyer Children's Hospital, Florence, Italy · Mansoura University · University of Utah, Salt Lake City, UT, USA · University of Iowa Carver College of Medicine, Iowa City, IA, USA · Ann & Robert H Lurie Children's Hospital of Chicago · Palacky University Olomouc Institute of Molecular and Translational Medicine, Olomouc, Czechia · Alder Hey Children's NHS Foundation Trust · University of Calgary, Calgary, Alberta, Canada
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04725422 on ClinicalTrials.govOther trials for Chronic nonbacterial osteomyelitis/Chronic recurrent multifocal osteomyelitis
Additional recruiting or active studies for the same condition.
See all trials for Chronic nonbacterial osteomyelitis/Chronic recurrent multifocal osteomyelitis →